RxDoctor Payments Data

Michelle Hill, DO

Psychiatry · Rolla, MONPI 1679894232

Payments from drug & device makers

$510in general payments, 2019–2025

Across 35 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$185
  • AbbVie$133
  • Otsuka America Pharmaceutical, Inc.$51
  • Neurocrine Biosciences, Inc.$42
  • Lundbeck LLC$37
  • Takeda Pharmaceuticals U.S.A., Inc.$32
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$50399%
  • Education$71%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$510 in reported general payments places this provider in the 60th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$10,330
Medicare patients
23
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate28$99,096
Lurasidone Hcl21$24,728
VyvanseLisdexamfetamine Dimesylate14$5,311
Aripiprazole78$4,529
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine67$3,928
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine126$3,857
Lisdexamfetamine Dimesylate19$3,791
Desvenlafaxine Succinate ErDesvenlafaxine Succinate25$2,380
Paliperidone ErPaliperidone21$2,000
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate18$1,956
Olanzapine41$1,571
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl11$1,500
Bupropion XlBupropion Hcl62$1,082
Quetiapine Fumarate52$755
Clonazepam78$644

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$185$99,09628 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$32$5,31114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →